Bausch + Lomb has named Fred Hassan as chairman of the Board of Directors and has named Brent Saunders as chief executive officer and appointed him to the Board of Directors, effective immediately.
Current Chairman and CEO Gerald M. Ostrov is retiring, and will serve as a consultant to the new leaders.
Mr. Hassan is one of the leading figures in global healthcare. He served most recently as chairman and CEO of Schering-Plough Corporation until its merger with Merck & Co. in November 2009. He led a six-year transformation of Schering-Plough from a company under severe stress into one of the highest performing companies in the research-based global pharmaceutical industry, with a rich late-stage pipeline. Previously Mr. Hassan was chairman and CEO of Pharmacia Corporation, where he also executed a historic turnaround. Earlier in his career, Mr. Hassan was president of the U.S. operations of Wyeth and held positions of increasing importance at Novartis. He has served as a senior advisor to Warburg Pincus LLC, the private equity investing group, since November 2009. Warburg Pincus is the majority owner of Bausch + Lomb.
Más
Dijimos de él que era un "hombre que sabía demasiado".
Ahora...tendrá que ponerse "en los lentes"
Imagen "prestada" de Pharma Giles
Entradas
No hay comentarios:
Publicar un comentario